Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 33


Insulin Resistance as a Link between Amyloid-Beta and Tau Pathologies in Alzheimer's Disease.

Mullins RJ, Diehl TC, Chia CW, Kapogiannis D.

Front Aging Neurosci. 2017 May 3;9:118. doi: 10.3389/fnagi.2017.00118. eCollection 2017.


Cytokines and Cytokine Receptors Involved in the Pathogenesis of Alzheimer's Disease.

Nagae T, Araki K, Shimoda Y, Sue LI, Beach TG, Konishi Y.

J Clin Cell Immunol. 2016 Aug;7(4). pii: 441. Epub 2016 Aug 4.


Novel Roles for the Insulin-Regulated Glucose Transporter-4 in Hippocampally Dependent Memory.

Pearson-Leary J, McNay EC.

J Neurosci. 2016 Nov 23;36(47):11851-11864.


Is Alzheimer's disease a Type 3 Diabetes? A critical appraisal.

Kandimalla R, Thirumala V, Reddy PH.

Biochim Biophys Acta. 2017 May;1863(5):1078-1089. doi: 10.1016/j.bbadis.2016.08.018. Epub 2016 Aug 25. Review.


Unraveling Alzheimer's: Making Sense of the Relationship between Diabetes and Alzheimer's Disease1.

Schilling MA.

J Alzheimers Dis. 2016;51(4):961-77. doi: 10.3233/JAD-150980. Review.


Hyperamylinemia as a risk factor for accelerated cognitive decline in diabetes.

Ly H, Despa F.

Expert Rev Proteomics. 2015;12(6):575-7. doi: 10.1586/14789450.2015.1104251. Epub 2015 Oct 26. Review.


Asparaginase treatment side-effects may be due to genes with homopolymeric Asn codons (Review-Hypothesis).

Banerji J.

Int J Mol Med. 2015 Sep;36(3):607-26. doi: 10.3892/ijmm.2015.2285. Epub 2015 Jul 15. Review.


Insulin Regulates the Activity of the High-Affinity Choline Transporter CHT.

Fishwick KJ, Rylett RJ.

PLoS One. 2015 Jul 10;10(7):e0132934. doi: 10.1371/journal.pone.0132934. eCollection 2015.


Amylin at the interface between metabolic and neurodegenerative disorders.

Lutz TA, Meyer U.

Front Neurosci. 2015 Jun 16;9:216. doi: 10.3389/fnins.2015.00216. eCollection 2015. Review.


Aberrant insulin signaling in Alzheimer's disease: current knowledge.

Bedse G, Di Domenico F, Serviddio G, Cassano T.

Front Neurosci. 2015 Jun 16;9:204. doi: 10.3389/fnins.2015.00204. eCollection 2015. Review.


Link between type 2 diabetes and Alzheimer's disease: from epidemiology to mechanism and treatment.

Li X, Song D, Leng SX.

Clin Interv Aging. 2015 Mar 10;10:549-60. doi: 10.2147/CIA.S74042. eCollection 2015. Review.


Redox proteomics analysis to decipher the neurobiology of Alzheimer-like neurodegeneration: overlaps in Down's syndrome and Alzheimer's disease brain.

Butterfield DA, Di Domenico F, Swomley AM, Head E, Perluigi M.

Biochem J. 2014 Oct 15;463(2):177-89. doi: 10.1042/BJ20140772. Review.


Type 3 diabetes is sporadic Alzheimer׳s disease: mini-review.

de la Monte SM.

Eur Neuropsychopharmacol. 2014 Dec;24(12):1954-60. doi: 10.1016/j.euroneuro.2014.06.008. Epub 2014 Jun 28. Review.


Insulin resistance predicts brain amyloid deposition in late middle-aged adults.

Willette AA, Johnson SC, Birdsill AC, Sager MA, Christian B, Baker LD, Craft S, Oh J, Statz E, Hermann BP, Jonaitis EM, Koscik RL, La Rue A, Asthana S, Bendlin BB.

Alzheimers Dement. 2015 May;11(5):504-510.e1. doi: 10.1016/j.jalz.2014.03.011. Epub 2014 Jul 17.


CSF and Brain Indices of Insulin Resistance, Oxidative Stress and Neuro-Inflammation in Early versus Late Alzheimer's Disease.

Lee S, Tong M, Hang S, Deochand C, de la Monte S.

J Alzheimers Dis Parkinsonism. 2013 Oct 31;3:128.


Elevated risk of type 2 diabetes for development of Alzheimer disease: a key role for oxidative stress in brain.

Butterfield DA, Di Domenico F, Barone E.

Biochim Biophys Acta. 2014 Sep;1842(9):1693-706. doi: 10.1016/j.bbadis.2014.06.010. Epub 2014 Jun 17. Review.


Limited brain metabolism changes differentiate between the progression and clearance of rabies virus.

Schutsky K, Portocarrero C, Hooper DC, Dietzschold B, Faber M.

PLoS One. 2014 Apr 24;9(4):e87180. doi: 10.1371/journal.pone.0087180. eCollection 2014.

Supplemental Content

Support Center